Pacific Biosciences of California, Inc. (PACB)

PACB Revenue

In the year 2023, Pacific Biosciences of California had annual revenue of $200.52M with 56.29% growth. Revenue in the quarter ending December 31, 2023 was $58.36M with 113.35% year-over-year growth.

• Revenue (ttm): $200.52M
• Revenue Growth: +56.29%
• P/S Ratio: 2.26
• Revenue / Employee: $251,911
• Employees: 796
• Market Cap: 458.04M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	200.52M	72.22M	56.29%
Dec 31, 2022	128.30M	-2.21M	-1.69%
Dec 31, 2021	130.51M	51.62M	65.43%
Dec 31, 2020	78.89M	-12.00M	-13.20%
Dec 31, 2019	90.89M	12.27M	15.60%
Dec 31, 2018	78.63M	-14.84M	-15.88%
Dec 31, 2017	93.47M	2.75M	3.04%
Dec 31, 2016	90.71M	-2.07M	-2.23%
Dec 31, 2015	92.78M	32.19M	53.12%
Dec 31, 2014	60.59M	32.41M	115.02%
Dec 31, 2013	28.18M	2.20M	8.46%
Dec 31, 2012	25.98M	-7.88M	-23.27%
Dec 31, 2011	33.86M	32.19M	1,922.88%
Dec 31, 2010	1.67M	1.54M	1,140.00%
Dec 31, 2009	135.00K	-766.00K	-85.02%
Dec 31, 2008	901.00K	-1.26M	-58.34%
Dec 31, 2007	2.16M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.